Wednesday, September 20, 2017

Allergan: Is Imprimis Spat Another Ruse To Crush Restasis Competitor ...

https://seekingalpha.com › Investing Ideas › Quick Picks & Lists › Healthcare
5 hours ago - IMMY is expected to come to market with a drug to treat dry eye, putting it in competition with Restasis. Is the spat another attempt to crush a Restasis competitor ...

No comments: